Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study
Glucocorticoid administration is a common clinical practice that attempts to decrease the inflammation associated with and improve the resectability of canine mast cell tumors (MCTs). However, the impact of neoadjuvant glucocorticoids on the histological features and proliferation indices of canine...
Main Authors: | Shawna Klahn, Nikolaos Dervisis, Kevin Lahmers, Marian Benitez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/9/6/277 |
Similar Items
-
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone
by: Thais Rodrigues Macedo, et al.
Published: (2022-02-01) -
Τhe Effect of Opioid Administration on Cytologic and Histopathologic Diagnosis of Canine Cutaneous Mast Cell Tumors Treated by Surgical Excision
by: Christina Marouda, et al.
Published: (2022-04-01) -
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors
by: Andrigo Barboza de Nardi, et al.
Published: (2022-02-01) -
The Role of Fine Needle Aspiration of Liver and Spleen in the Staging of Low-Grade Canine Cutaneous Mast Cell Tumor
by: Valentina Rinaldi, et al.
Published: (2022-09-01) -
Characterization of WWOX expression and function in canine mast cell tumors and malignant mast cell lines
by: Rebecca Makii, et al.
Published: (2020-10-01)